Valuation: Inhalation Sciences Sweden AB

Market Cap 7.07M 716K 625K 590K 536K 1M 68.74M 1.01M 2.73M 34.95M 2.69M 2.63M 112M P/E 2024
-12.8x
P/E 2025 -12.4x
Enterprise Value 4.23M 429K 374K 353K 321K 601K 41.2M 604K 1.63M 20.94M 1.61M 1.58M 67.39M EV / Sales 2024
5.6x
EV / Sales 2025 55x
Free-Float
99.4%
Yield 2024 *
-
Yield 2025 -
1 day+1.47%
1 week+11.29%
Current month-5.80%
1 month-10.68%
3 months-40.52%
6 months-42.02%
Current year-96.82%
1 week 0.11
Extreme 0.113
0.14
1 month 0.06
Extreme 0.0608
0.18
Current year 0.06
Extreme 0.0608
0.58
1 year 0.06
Extreme 0.0608
0.58
3 years 0.06
Extreme 0.0608
4.99
5 years 0.06
Extreme 0.0608
11.3
10 years 0.06
Extreme 0.0608
15.48
Manager TitleAgeSince
Chief Executive Officer - 16/09/2019
Chief Tech/Sci/R&D Officer - 01/01/2005
Corporate Officer/Principal - 02/06/2025
Director TitleAgeSince
Director/Board Member - 01/01/2005
Director/Board Member - 01/09/2022
Director/Board Member - 01/09/2024
Change 5-day change 1-year change 3-year change Capi.($)
+1.47%+11.29%-96.82%-95.74% 716K
-1.04%+6.83%+35.84%+29.03% 241B
-0.32%+5.83%+9.58%-16.76% 149B
+2.55%+6.55%-10.35%+34.72% 139B
-0.48%+0.84%-55.70%-19.89% 62.81B
+0.01%+4.61%+18.61%+22.67% 50.87B
+0.04%-3.00%-19.38%-17.32% 48.21B
+0.08%+6.49%+23.87%+39.12% 44.11B
-1.88%+3.25%+40.14%+53.82% 41.42B
-2.27%+16.07%+133.21%+73.20% 36.18B
Average -0.18%+4.68%+7.90%+10.28% 81.23B
Weighted average by Cap. -0.16%+5.73%+15.60%+18.46%

Financials

2024 2025
Net sales 11.05M 1.12M 977K 922K 837K 1.57M 107M 1.58M 4.26M 54.64M 4.21M 4.11M 176M 3.04M 308K 269K 254K 231K 432K 29.59M 434K 1.17M 15.04M 1.16M 1.13M 48.4M
Net income -5.15M -522K -455K -430K -390K -731K -50.08M -734K -1.99M -25.46M -1.96M -1.92M -81.92M -10.16M -1.03M -898K -848K -770K -1.44M -98.85M -1.45M -3.92M -50.26M -3.87M -3.78M -162M
Net Debt -4M -406K -354K -334K -303K -569K -38.95M -571K -1.54M -19.8M -1.52M -1.49M -63.71M -2.83M -287K -250K -236K -215K -402K -27.54M -404K -1.09M -14M -1.08M -1.05M -45.06M
Logo Inhalation Sciences Sweden AB
Inhalation Sciences Sweden AB is a Sweden-based company, which develops and sells labtech equipment for inhalation research. The Company’s primary product is PreciseInhale, which is a laboratory system that lets scientists measure how inhaled particles act in lungs and affect human health. PreciseInhale is a dry powder aerosol research and development system, which generate aerosols and data of a quality. The system helps to eliminate poor candidate drugs before clinical trials. The secondary product is LaminarPace, a tool for drying small amounts of drug substance. The Company’s customers comprise Dow Chemical Group, Kings College London and Karolinska Institutet, among others. The Company’s main shareholder is Nordnet Pensionsforsakring.
Employees
5
Date Price Change Volume
17/09/26 SEK 0.1380 +1.47% 101,571
16/09/26 SEK 0.1360 +0.37% 1,000
14/09/26 SEK 0.1355 +9.27% 50,935

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ISAB Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!